DrugPatentWatch Database Preview
Details for Patent: 7,838,027
Which drugs does patent 7,838,027 protect, and when does it expire?
Protection for PROTONIX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-four patent family members in twenty-seven countries.
Summary for Patent: 7,838,027
Title: | Pantoprazole multiparticulate formulations |
Abstract: | Pantoprazole sodium multiparticulates are described which avoid sticking to nasogastric and gastronomy tubes. The pantoprazole multiparticulates have a spheroid core of pantoprazole or an enantiomer thereof, or a salt thereof, a surfactant, and a disintegrant; a sub coat which is comprised of hydroxypropyl methylcellulose (hypromellose) and water, an enteric coat on the sub-coat, and a final seal coat over the enteric coat, which is composed of hydroxypropyl methylcellulose (hypromellose) and water. |
Inventor(s): | Venkata Ramana Rao; Sripriya (Iselin, NJ), Shah; Syed M. (East Hanover, NJ), Tatapudy; Hanumantharao (Suffern, NY), Saunders; Richard William (Palisades, NY), Fawzi; Mahdi (Morristown, NJ), Nagi; Arwinder (Thiells, NY), Singh; Shailesh (Bardonia, NY), Hasan; Sumon A. (Monroe, NY) |
Assignee: | Wyeth LLC (Madison, NJ) |
Application Number: | 10/574,210 |
Patent Claim Types: see list of patent claims | Compound; Dosage form; Use; Formulation; |
Drugs Protected by US Patent 7,838,027
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Pharms Inc | PROTONIX | pantoprazole sodium | FOR SUSPENSION, DELAYED RELEASE;ORAL | 022020-001 | Nov 14, 2007 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Foreign Priority and PCT Information for Patent: 7,838,027
PCT Information | |||
PCT Filed | September 30, 2004 | PCT Application Number: | PCT/US2004/033058 |
PCT Publication Date: | April 14, 2005 | PCT Publication Number: | WO2005/032513 |
Non-Orange Book US Patents Family Members for Patent 7,838,027
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
Patent No. | Title | Estimated Patent Expiration |
---|---|---|
7,553,498 | Pantoprazole multiparticulate formulations | ➤ Try a Free Trial |
7,544,370 | Pantoprazole multiparticulate formulations | ➤ Try a Free Trial |
7,550,153 | Pantoprazole multiparticulate formulations | ➤ Try a Free Trial |
Patent No. | Title | Estimated Patent Expiration |
International Family Members for US Patent 7,838,027
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 045956 | ➤ Try a Free Trial | |||
Australia | 2004278037 | ➤ Try a Free Trial | |||
Brazil | PI0415014 | ➤ Try a Free Trial | |||
Canada | 2539982 | ➤ Try a Free Trial | |||
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |